Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-04-30 | "Dr. Japour’s qualifications... include his over 25 years of experience in the pharmaceutical and biotechnology businesses." |
| 2020-04-28 | “Dr. Japour’s qualifications to serve on our Board of Directors include his over 25 years of experience in the pharmaceutical and biotechnology businesses.” |
| 2021-04-26 | "Dr. Japour’s qualifications to serve on our Board include his over 25 years of experience in the pharmaceutical and biotechnology businesses." |
| 2022-04-11 | "Dr. Japour’s qualifications to serve on our Board include his over 25 years of experience in the pharmaceutical and biotechnology businesses." |
| 2023-04-28 | "Dr. Japour has been the Chief Executive Officer of iTolerance, Inc.... [and] has over 25 years of experience in the pharmaceutical and biotechnology businesses." |
| 2024-05-07 | "Dr. Japour has over 25 years of experience in the pharmaceutical and biotechnology businesses. Additionally, Dr. Japour has extensive experience in the clinical trial process." |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25